-
Consensus Rating
HoldBased on 28 Analyst Ratings
-
Consensus Price Target
$952.23-16.69% Downside
Recent Analyst Forecasts and Stock Ratings
Regeneron Pharmaceuticals, Inc. Frequently Asked Questions
-
What analysts cover Regeneron Pharmaceuticals, Inc.?
Regeneron Pharmaceuticals, Inc. has been rated by research analysts at BMO Capital, RBC Capital, Raymond James, Bank of America Securities, Guggenheim, UBS in the past 90 days.